Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
TRNR Interactive Strength shares slide 727 after Q4 2025 earnings massively miss analyst EPS expectations WHWK Whitehawk Therapeutics falls 336 as Q4 2025 EPS misses estimates by a wide 1164 percent margin SLB SLB Unusual Block Call Options Activity Signals Elevated Bullish Sentiment Through Mid2026 QTTB Q32 Bio posts massive EPS beat yet shares dip despite blowout quarter Lebanon Reports Six Killed in Israeli Strike Amid US Ceasefire Extension Geopolitical Tensions Weigh on Regional Markets Jim Cramer Optimistic on Marvell It Can Go Higher What Investors Should Know US Holds Advantage in AI Talks with China Bessent Tells CNBC as Nations Work on Safety Protocol Global Companies Face 32 Billion Iran War Toll as Earnings Impact Looms Trump Reverses AI Executive Order Dropping Safety Review Requirement for New Models Earnings Calendar Week of May 2529 Market Insights and Investor Considerations JhunjhunwalaPartnered Fund Acquires Stake in Tourism Finance Corporation of India TFCI MD Discusses Business Outlook UK Exports to US Plunge 25 Following Trump Tariffs Resulting in Trade Deficit Russian Oil Arrivals in Singapore Increase Amid Legal Trade Framework M R Maniveni Foods IPO Day 1 Subscription Reaches 65 Led by NIIs Key Details Inside Federated Hermes Inc FHI Q1 2026 Earnings Solid EPS Beat Drives Positive Market Response LCTX Q1 2026 Earnings Widerthanexpected loss as clinicalstage biotech advances pipeline ZTS Q1 2026 Earnings EPS Falls Short of Expectations as Stock Edges Higher CIB Q4 2025 Earnings Massive EPS Miss as Company Reports Deep Loss Garrett Motion GTX Q1 2026 Earnings EPS Surpasses Estimates by 1486 Shares Edge Higher NovaBridge Biosciences NBP Q4 2025 Earnings Staggering EPS Miss as PreRevenue Biotech Faces Development Headwinds Iterum Therapeutics ITRM Holds at 003 as MicroCap Biotech Waits for Catalysts Dycom Industries DY Nears Support After Modest Decline Decoy Therapeutics DCOY Surges 135 Testing Key Resistance at 767 Nuveen Core Plus Impact Fund NPCT Holds Steady Near Key Support Levels American Battery Technology Company ABAT Edges Higher as Battery Sector Momentum Builds